Xiaodong joined NEA in 2005 to focus on investments in the rapidly growing China markets. In December 2005, he launched New Enterprise Associates (Beijing)Ltd. and opened its Beijing and Shanghai offices. Xiaodong currently manages all NEA's China related investment activities. Xiaodong's areas of interest inlude growth venture equity opportunities in technology, consumer and healthcare sectors. Xiaodong's recent investments include CITIC Pharmaceuticals (acquired by Shanghai Pharma 601607.SS), Redbaby, Uni-Power Group, Lianlian Pay, Novast Pharmaceuticals, NexChem Pharmaceuticals, HYGEIA Medical Services, LineKong, Cathay Biotech, and baihe.com. He has also worked closely with management at Spreadtrum (NASDAQ: SPRD) and Availink.

Xiaodong received a Master's degree from the University of Illinois and a bachelor's degree from Nanjing University in China. He was a doctoral candidate in computer science at University of California, Berkeley.